Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
157
act as entrance barriers, or the liver’s initial processing stage, medications adminis-
tered intravenously are more readily available. Giving medications that are difcult
for the stomach to process is often done in this manner. It is also rapid and improves
the drug’s effectiveness in this manner (Chaito etal. 2016).
8.5.1 Compatibility andStability
When adding inulin into oral formulas, stability and suitability are important factors
to ensure safety and effectiveness of injected medicines. The natural polysaccharide
inulin has shown great tolerance with a range of medicines, such as antibiotics, pain
killers, and anti-inammatory agents, which are often included in injectable prod-
ucts (Paolini etal. 2006). It may be quickly added to water-based mixes such as
emulsions, suspensions, and watery solutions since it dissolves easily in water. The
stability and suitability of inulin in injectable forms add to its exibility as an excip-
ient helps in drug absorption, stability, and solubility (Tonnis etal. 2015).
8.5.2 Applications inInjectable Formulations
Because of its unique qualities and advantages, inulin is often used in injectable
formulations. Inulin is a practical pharmaceutical excipient that is used in injectable
formulations for many purposes, including the following:
1. Sustained Release: A sustained-release drug called inulin improves medication
release, which enhances treatment efciency. By forming a mesh with active
pharmaceutical ingredient (API), inulin slows down transport and uptake of
medicine, resulting in controlled and delayed release rates.
2. Solubility Enhancement: Inulin is a wonderful excipient for improving solubility
of medicines that are badly soluble in injection solutions since it is soluble in
water. By improving drug solubility, inulin is said to improve treatment results
and medicine absorption.
3. Stabilization: Inulin adds to chemistry and physical safety of injected uids. The
prevention of drug breakdown, clumping, or precipitation helps in keeping use-
fulness and safety of API throughout application and storage.
4. Biocompatibility: Inulin is safe and nontoxic; therefore injectable forms of the
substance are suitable. Because injectable formulations don’t have negative side
effects or signicant immunological responses, they are safe (Leyva Porras
etal. 2021).
5. Controlled Delivery: Inulin-based injectable treatments allow precise regulation
of medication delivery rates. Whether hydrogels, nanoparticles, or microparti-
cles, inulin facilitates the development of delivery methods tailored to specic
medicinal requirements.
6. Enhanced Targeting: Inulin may be functionalized or combined with targeting
proteins to enable site-specic medication delivery. By enhancing medication
8 Inulin asaPharmaceutical Excipient
158
accumulation at the desired site of action, this targeted approach reduces off-
target effects and increases therapeutic efcacy (Tripodo et al. 2015; Hester
etal. 2018).
8.5.3 Regulatory Considerations
Regulations concerning inulin in parenteral formulae are signicant because they
must be followed to guarantee compliance with guidelines established by regulatory
authorities. Ensuring the quality, safety, and efcacy of pharmaceutical products is
the aim of these regulations (Sardo etal. 2016). Additionally, according to the rel-
evant pharmacopeial standards and recommendations, it is necessary to comply
with legal obligations. Experimental and clinical studies are conducted to evaluate
the safety and effectiveness of inulin in parenteral formulations; these studies pro-
vide crucial data for regulatory submissions. Taking everything into account, care-
ful consideration of regulatory matters is necessary to guarantee the efcacy and
safety of inulin in injectable forms (Kesharwani etal. 2019).
8.6 Inulin inTopical andTransdermal Formulations
8.6.1 Infiltration andPermeation oftheSkin
It has been studied how inulin may improve the skin’s ability to absorb and enter
active ingredients included in cosmetic and transdermal goods. Because inulin is
nontoxic and may form porous structures, it goes through the skin barrier to boost
effectiveness and absorption of medicines. It is a sought-after excipient because of
its ability to move medicines via skin for either local or broad effects (Puley
etal. 2016).
8.6.2 Methods ofFormulation
It has been studied how inulin may improve the skin’s ability to absorb and enter
active ingredients included in makeup and transdermal goods. Because inulin is safe
and may make porous structures, it goes through the skin barrier to boost usefulness
and absorption of drugs. It is a wanted excipient because of its ability to move medi-
cines through the skin for either local or broad effects (Hokhodchi and
Rubinstein 1996).
8.6.3 Applications inDermatology
Inulin is an ingredient in a wide variety of medicinal products, including gels,
creams, lotions, and patches. It is a part of products that treat acne, psoriasis,
V. Mittal et al.
159
eczema, and fungal infections. Inulin is a suitable match for skincare products that
aim to moisturize and protect the skin barrier because, in addition to its capacity to
transport medicines, it also has a cooling and moisturizing impact on skin (Bolhuis
and Zuurman 1995).
8.7 Inulin inOral Liquid Formulations
For the patient to take the medication, it must dissolve in solid form in the mouth.
Thus, decreased bioavailability of poorly soluble medications may be due to their
poor dissolving and releasing characteristics. Solid dispersion (SD) is a well-known
technique for improving release rates and dissolving poorly soluble medications
(Bolhuis etal. 1985). To create SD, a hydrophilic carrying substance known as IN
is often added. Nowadays, oral administration is considered the most effective mode
of therapy. Therefore, developing medication delivery techniques specically tar-
geted to the colon is crucial for the treatment of colon illnesses (Hinrichs etal.
2001). The medication must dissolve in solid oral preparations before it may be
consumed. Drugs with poor breakdown rates and release patterns thus have poor
absorption rates. Methods like solid dispersion might enhance the ease of break-
down and release prole of medications. Using hydrophilic carriers accelerates the
melting of the solid mixture and increases absorption (Bos etal. 1991). Furthermore,
since inulin is hydrophilic, medication release, solubility, and absorption are all
slightly enhanced by using it as a carrier in tablet forms. When compared to sugar
or other carbohydrates, inulin signicantly enhanced solubility characteristics in a
diazepam dissolving rate investigation (Cedgard 1997). Figure8.4 shows probiotic
effects of inulin.
8.7.1 Emulsion andSuspension Stabilization
In oral liquid foods, inulin functions as a binder for emulsions and solutions. Its
capacity to form a gel-like substance prevents phase separation and particle settling,
ensuring even distribution and consistency of the product. Pharmaceutical emul-
sions and solutions with this stabilizing characteristic have longer shelf lives and
physical stability, maintaining their medicinal effectiveness over time (De Boer
etal. 1978).
8.7.2 Formulations forSyrup andElixir
Inulin is often used in syrup and beverage recipes as a stiffening and sweetening
component. Mouth drinks taste better and are easier to administer, particularly for
elderly and paediatric patients, because of the slight sweetness that offers them
palatability. Additionally, the thickening properties of inulin assure the right
8 Inulin asaPharmaceutical Excipient
160
Fig. 8.4 Prebiotic effects of inulin
quantity and improve the ow characteristics of commodities, enhancing the thick-
ness of syrups and elixirs (De Leenheer and Hoebregs 1994).
8.7.3 Effects ofTaste Masking
Inulin has taste-masking properties in oral liquid formulations because it lessens the
perception of sour or unpleasant avours associated with certain active compounds.
Because the medication masks bitterness with mild sweetness and bland avour,
patients nd it more tolerable and acceptable. This taste-masking effect is quite
helpful in increasing patient behaviour, particularly for younger and older individu-
als (Bolhuis etal. 1975; Armstrong 1990).
8.8 Inulin inNanoparticle andMicroparticle Formulations
Adsorption, adhesion, or trapping have all been used by inulin microparticles to
transport drugs, proteins, vaccine antigens, and other materials. Depending on the
necessary physiochemical properties, inulin microparticles may be produced chem-
ically or physically. Using a medicine or active component relies on its chemical
properties and the required particle size (Shivkumar etal. 2006). The biodegrad-
ability of inulin is crucial when used as microparticles because it releases drug
cargo that was previously contained in the matrix when the particle degrades.
V. Mittal et al.
161
Another reason to utilize inulin is that it has Food and Drug Administration (FDA)
approval. Additionally, the hydroxyl group in a molecule functions as a molecular
handle and change site (Bussemer etal. 2003). Several parameters may be altered
during the manufacture of inulin microparticles to modify the drug release and
breakdown rates. Moreover, since inulin particles may be functionalized with a par-
ticular ligand, they are an excellent and ideal carrier (Kshirsagar etal. 2009). When
inulin is modied, products with improved properties are produced without altering
the fundamental structure of the inulin backbone. There are reports of the use of
inulin microparticles as a delivery system and adjuvant for vaccinations. For
instance, it has been shown that delta inulin microparticles possess potent immuno-
modulatory properties, making them a perfect adjuvant that also supports vaccina-
tions (Gao etal. 2006). When the antigen was added to inulin microparticles, it was
precisely transported to antigen-presenting cells (APCs) and produced adjuvant
effects (dual function). As vaccine adjuvants and delivery systems, semicrystalline
inulin particles—particularly delta inulin—showed promising results (Epstein
2015). Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM)
morphology investigations visually dened these semicrystalline forms of inulin,
demonstrating that they are standard discoid structures composed of lamellar sheet
piles with a width of around 1–2μm. This facilitates their faster uptake by mono-
cytes (Gupta etal. 2001). The distinct size of the γ-inulin microparticles facilitates
their efcient internalization by antigen- presenting cells (APCs) (Hauser Kawaguchi
etal. 2019).
8.8.1 Applications ofNanotechnology
Growing uses of inulin in nanotechnology are offering state-of-the-art solutions for
a variety of industries, including as medicine administration, imaging, and detec-
tion. One such application is the production of inulin-based nanoparticles for drug
delivery systems (Aulton 2002). These nanoparticles may include healing chemi-
cals to avoid breakdown and allow specic transport to certain organs or cells. All
things considered, inulin’s biocompatibility and exibility make it a great choice for
many nanotechnology uses, opening new paths for better tests and precision medi-
cine (Akhgari etal. 2009).
8.8.2 Systems ofControlled Release
Inulin in nanoparticle and microparticle forms with controlled release mechanisms
may be given using a range of drug administration methods. When packaging medi-
cines in nanoparticle form, inulin may be employed as a glue material to allow
constant release over a longer period of time (Sharma and Pathak 2012). By chang-
ing production characteristics such particle size, substance, and surface qualities,
release rates of capsule medicine may be exactly changed to obtain desired treat-
ment effects. All things considered, adding inulin into nanoparticle- and
8 Inulin asaPharmaceutical Excipient
162
microparticle- containing materials may be a means of making controlled-release
goods with better safety and effectiveness proles (Smolenska etal. 1999).
8.8.3 Improvement ofBioavailability
There is hope that increasing inulin’s intake in nanoparticle and microparticle types
would increase its medicinal usefulness. By encasing inulin in nanoparticles or mic-
roparticles, it may be made more liquid and rm, improving the body’s intake and
use of it. Liposomes and polymeric nanoparticles, two types of nanoparticle forms,
have the advantage of focused distribution to specic organs or cells, longer circula-
tion lengths, and protection of inulin against breakdown (Zhu and Zheng 2005). All
things considered, mixtures of microparticles and nanoparticles show promise in
terms of improving uptake of inulin and, therefore, its value in a variety of medical
uses (Traynor etal. 2006).
8.9 Regulatory Considerations
Regulatory considerations for inulin as a pharmaceutical excipient are essential to
ensure its safe and effective use in drug formulations.
8.9.1 Present State ofRegulation
Inulin has been categorized as generally accepted as safe by regulatory bodies such
as the USFDA and the European Medicines Agency (EMA). However, its exact
legal standing as a medicine excipient may change based on nation and expected
use. Pharmacopoeias or papers relating to certain areas describe quality and cleanli-
ness standards may include inulin (Broesder etal. 2021).
8.9.2 Analytical Techniques andQuality Control
Pharmaceutical makers need to set up quality control processes and testing tech-
niques to ensure identication, clarity, and quality of inulin used in medical solu-
tions. These methods often involve tests for content of bacteria, analysis,
identication, poisons, and particle size distribution (Srinarong etal. 2009).
8.9.3 Toxicology andSafety asanExcipient
Safety studies are important to studying possible risks involved with use of inulin as
an excipient. Toxicology studies are run to measure safety features of inulin, such as
its mutagenicity, acute toxicity, genotoxicity, and chronic toxicity (Wahjudi etal.
V. Mittal et al.
163
2013). These studies help in nding suitable daily dose sizes and discover any bad
effects linked with its usage (Saluja etal. 2010).
8.10 Future Perspectives andEmerging Trends
8.10.1 Progress inInulin Study
Inulin has a bright future as an excipient in medical with a plethora of advances and
their novel uses. The present study aims to improve medication efciency and
patient results by exploring new formulas and transfer methods that use inulin.
Advances in nanotechnology have made it possible to make inulin-based nanopar-
ticles and microparticles for personalized drug delivery improve stability and
delayed release qualities (Haj-Ahmad etal. 2013).
8.10.2 Difficulties andPossibilities asRecipients
Despite all of its advantages, inulin has a few drawbacks when used as a medicinal
excipient. Natural inulin’s source and compositional variability are a major issue as
it might affect the product’s physical characteristics and cooking efcacy. Inulin has
to specify its inputs and output techniques in order to be consistent and dependable.
These issues also provide opportunities for innovation and collaboration within the
pharmaceutical industry, as well as with regulatory and study partners, to satisfy the
growing demand for safe and efcient excipients (Grasmeijer etal. 2013).
8.11 Conclusion
In conclusion a versatile polysaccharide, inulin, has several health advantages and
may be used as a dietary bre, a medication delivery system, or a diagnostic tool. A
lot of studies have been done on inulin and its use in medication administration. The
most common use for inulin is colon-targeted medication administration. The pri-
mary cause is its ability to withstand the stomach’s acidic environment. Numerous
techniques make use of this special stability and power to safely transport medica-
tions to the colon, where they are readily absorbed into the bloodstream via gut
epithelium. Hydrodynamic study based on inulin will be helpful in determining
potential of inulin. Because of this, inulin is a great option to be a carrier for bioma-
terials and medication delivery systems. Its chemical structure may be changed to
improve its utility. The alteration of inulin is anchored and catalysed by hydroxyl
group. One such nutritional item that has gained popularity in current period is inu-
lin. The microparticles and nanoparticle size range allow effective absorption by
macrophages and monocytes. Drugs with limited water solubility may have their
solubility and bioavailability improved by using solid dispersions made of inulin. It
is important to note that further research is necessary to fully understand potential
8 Inulin asaPharmaceutical Excipient
164
uses of inulin for pH-targeted, lysosome-triggered, and light-controlled
administration.
Acknowledgement None.
Conict of Interest The authors declare no conict of interest.
Funding None.
References
Akhgari A, Afrasiabi GH, Sadeghi F (2009) Combination of inulin & time dependent polymeth-
acrylates as a coating system to achieve colonic delivery of indomethacin. DARU J Pharm Sci
17:199–209
Armstrong NA (1990) Considerations of compression speed in tablet ller-binder for direct com-
paction of tablets. Pharm Technol Int 5:19–27
Aulton ME (2002) Powder ow in pharmaceutics the science of dosage form design. Churchill
Livingstone, London
Barclay T, Ginic-Markovic M, Cooper P, Petrovsky N (2010) Inulin—a versatile polysaccharide
with multiple pharmaceutical & food chemical uses. J Excip Food Chem 1:27–50
Bolhuis GK, Lerk CF, Zijlstra HT, De Boer AH (1975) Film formation by magnesium stearate
during mixing & its effect on tableting. Pharm Weekbl 110:317–325
Bolhuis GK, Reichman G, Lerk CF, Van Kamp HV, Zuurman K (1985) Evaluation of anhydrous
a-lactose, a new excipient in direct compression. Drug Dev Ind Pharm 11:1657–1681
Bolhuis GK, Zuurman K (1995) Tableting properties of experimental & commercially available
lactose granulations for direct compression. Drug Dev Ind Pharm 21(18):2057–2071
Bos CE, Vromans H, Lerk CF (1991) Lubricant sensitivity in relation to bulk density for granula-
tions based on starch or cellulose. Int J Pharm 67:39–49
Broesder A, Berends JME, Scheepers SM, Nguyen DN, Frijlink HW, Hinrichs WLJ (2021) Ileo-
colon targeting of the poorly water-soluble drug celecoxib using a pH-dependent coating in com-
bination with self-emulsifying drug delivery or solid dispersion systems. Pharmaceutics 13:731
Bussemer T, Peppas NA, Bodmeier R (2003) Time-dependent mechanical properties of polymeric
coatings used in rupturable pulsatile release dosage forms. Drug Dev Ind Pharm 29:623–630
Carabin IG, Gary FW (1999) Evaluation of safety of inulin & oligofructose as dietary ber. Regul
Toxicol Pharmacol 30(3):268–282
Cedgard L (1997) Methods for the production of tablets by pressing & tablets produced by the
method. Int Pat. WO97/07822
Chaito C, Judprasong K, Puwastien P (2016) Inulin content of fortied food products in Thailand.
Food Chem 193:102–105
Clark DE (1999) Rapid calculation of polar molecular surface area & its application to the predic-
tion of transport phenomena: prediction of intestinal absorption. J Pharm Sci 88(8):807–814
De Boer AH, Bolhuis GK, Lerk CF (1978) Bonding characteristics by scanning electron micros-
copy of powders mixed with magnesium stearate. Powder Technol 20:75–82
De Leenheer L, Hoebregs H (1994) Progress in the elucidation of the composition of chicory
inulin. Starch-Starke 46:193–196
Devine DA, Marsh PD (2009) Prospects for the development of probiotics & prebiotics for oral
applications. J Oral Microbiol 1:1–12
Epstein JH (2015) A photometric method for the determination in plasma & urine of it is generally
accepted that, of the substances used to test glomerular ltration, inulin is the most satisfactory.
Determ Inulin Clear Inulin Inject Int 13:839–846
V. Mittal et al.
165
Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M (2001) Inulin & oligofructose as
dietary ber: a review of the evidence. Crit Rev Food Sci Nutr 41(5):353–362
Franck A (2002) Technological functionality of inulin & oligofructose. Br J Nutr 87(Suppl.
2):S287–S291
Gao C, Huang J, Jiao Y, Shan L, Liu Y, Li Y etal (2006) In vitro release & invivo absorption in
beagle dogs of meloxicam from Eudragit FS30D coated pellets. Int J Pharm 322:104–112
Grasmeijer N, Stankovic M, de Waard H, Frijlink HW, Hinrichs WLJ (2013) Unraveling protein
stabilization mechanisms: vitrication & water replacement in a glass transition temperature
controlled system. Biochim Biophys Acta Proteins Proteomics 1834:763–769
Gupta N, Jangid AK, Pooja D, Kulhari H (2019) Inulin: a novel & stretchy polysaccharide tool for
biomedical & nutritional applications. Int J Biol Macromol 132:852–863
Gupta VK, Beckert TE, Deusch NJ, Harinaraon M, Price JC (2001) A novel pH & time based multi
potential colonic drug delivery system. Int J Pharm 213:83–91
Haj-Ahmad RR, Elkordy AA, Chaw CS, Moore A (2013) Compare & contrast the effects of sur-
factants (Pluronic
®
F-127 & Cremophor
®
EL) & sugars (β-cyclodextrin & inulin) on properties
of spray dried & crystallised lysozyme. Eur J Pharm Sci 49:519–534
Hauser Kawaguchi A, Milne M, Li F, Lee TY, Luyt LG (2019) The development of a near-infrared
inulin optical probe for measuring glomerular ltration rate. Int J Biol Macromol 123:255–260
Hester SN, Mastaloudis A, Gray R, Antony JM, Evans M, Wood SM (2018) Efcacy of anthocy-
anin & prebiotic blend on the intestinal environment in obese male & female subjects. J Nutr
Metab 2018:7497260
Hines DJ, Kaplan DL (2013) Poly(lactic-co-glycolic) acid-controlled-release systems: experimen-
tal & modeling insights. Crit Rev Ther Drug Carrier Syst 30:257–276
Hinrichs WLJ, Prinsen MG, Frijlink HW (2001) Inulin glasses for the stabilization of therapeutic
proteins. Int J Pharm 215:163–174
Hokhodchi A, Rubinstein MH (1996) Compaction simulators in tableting research. Pharm Technol
Eur Yearbook 1996:6–67
Imran S, Gillis RB, Kok MS, Harding SE, Adams GG (2012) Application & use of inulin as a tool
for therapeutic drug delivery. Biotechnol Genet Eng Rev 28(1):33–46
Jimenez Sanchez M, Perez Morales R, Goycoolea FM, Mueller M, Praznik W, Loeppert R etal
(2019) Self-assembled high molecular weight inulin nanoparticles: enzymatic synthesis, physi-
cochemical & biological properties. Carbohydr Polym 215:160–169
Karimi R, Azizi MH, Ghasemlou M, Vaziri M (2015) Application of inulin in cheese as prebiotic,
fat replacer & texturizer: a review. Carbohydr Polym 119:85–100
Kaur N, Gupta AK (2002) Applications of inulin & oligofructose in health & nutrition. J Biosci
27:703–714
Keenan DF, Resconi VC, Kerry JP, Hamill RM (2014) Modelling the inuence of inulin as a fat
substitute in comminuted meat products on their physico-chemical characteristics & eating
quality using a mixture design approach. Meat Sci 96:1384–1394
Kelly G (2008) Inulin-type prebiotics. A review: part 1. Altern Med Rev 13:315–329
Kesharwani SS, Dachineni R, Bhat GJ, Tummala H (2019) Hydrophobically modied inulin-
based micelles: transport mechanisms & drug delivery applications for breast cancer. J Drug
Deliv Sci Technol 54:101–154
Kim Y, Faqih MN, Wang SS (2001) Factors affecting gel formation of inulin. Carbohydr Polym
46(2):135–145
Kocer D, Hicsasmaz Z, Bayindirli A, Katnas S (2007) Bubble & pore formation of the high-ratio
cake formulation with polydextrose as a sugar- & fat-replacer. J Food Eng 78:953–964
Koch K, Andersson R, Rydberg I, Åman P (1999) Inuence of harvest date on inulin chain length
distribution & sugar prole for six chicory (Cichorium intybus L) cultivars. J Sci Food Agric
79:1503–1506
Kshirsagar SJ, Bhalekar MR, Umap RR (2009) In vitro invivo comparison of two pH sensitive
Eudragit polymers for colon specic drug delivery. J Pharm Sci Res 1:61–70
Laguna L, Primo-Martín C, Salvador A, Sanz T (2013) Inulin & erythritol as sucrose replacers in
short-dough cookies: sensory, fracture, & acoustic properties. J Food Sci 78:S777–S784
8 Inulin asaPharmaceutical Excipient
166
Leyva Porras C, Lopez Pablos AL, Alvarez Salas C, Perez Urizar J (2021) Polysaccharides.
Polysaccharides 11:1–22
Leyva-Porras C, López-Pablos A, Alavrez-Salas C, Perez-Urizar J, Saavedra-Leos Z (2015)
Physical properties of inulin & technological applications. In: Ramawat KG, Mérillon JM (eds)
Polysaccharides. Springer, NewYork, NY, pp959–984
Lim TY, Poh CK, Wang W (2009) Poly (lactic-co-glycolic acid) as a controlled release delivery
device. J Mater Sci Mater Med 20:1669–1675
Liu J, Lu JF, Wen XY, Yuan X, Kan J, Jin CH (2015) Antioxidant & protective effect of inulin &
catechin grafted inulin against CCl4-induced liver injury. Int J Biol Macromol 72:1479–1484
Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug deliv-
ery systems. Adv Drug Deliv Rev 60:1650–1662
Mensink MA, Frijlink HW, Maarschalk KVDV, Hinrichs WL (2015) Inulin, a exible oligosac-
charide I: review of its physicochemical characteristics. Carbohydr Polym 130:405–419
Mittal S, Bajwa U (2011) Effect of fat & sugar substitution on the quality characteristics of low
calorie milk drinks. J Food Sci Technol 49:704–712
Mutanda T, Mokoena MP, Olaniran AO, Wilhelmi B, Whiteley CG (2014) Microbial enzymatic
production & applications of short-chain fructooligosaccharides & inulooligosaccharides:
recent advances & current perspectives. J Ind Microbiol Biotechnol 41:893–906
Ni D, Xu W, Zhu Y, Zhang W, Zhang T, Guang C etal (2019) Inulin & its enzymatic production
by inulosucrase: characteristics, structural features, molecular modications & applications.
Biotechnol Adv 37(2):306–318
Niness KR (1999) Inulin & oligofructose: what are they? J Nutr 129:1402–1406
Paolini G, Shapland R, Van Hoorn W (2006) Global mapping of pharmacological space. Nat
Biotechnol 24:805–815
Pasqualetti V, Altomare A, Guarino MPL, Locato V, Cocca S, Cimini S etal (2014) Antioxidant
activity of inulin & its role in the prevention of human colonic muscle cell impairment induced
by lipopolysaccharide mucosal exposure. PLoS One 9(9):e107405
Pintor A, Severiano-Pérez P, Totosaus A (2013) Optimization of fat-reduced ice cream formula-
tion employing inulin as fat replacer via response surface methodology. Food Sci Technol Int
20:489–500
Puley P, Kumar S, El Kourati F, Kesharwani SS, Tummala H (2016) Hydrophobically modied
inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intrave-
nous route. Int J Pharm 500:32–41
Rezaei R, Khomeiri M, Aalami M, Kashaninejad M (2014) Effect of inulin on the physico-
chemical properties, ow behavior & probiotic survival of frozen yogurt. J Food Sci Technol
51:2809–2814
Roberfroid M (1993) Dietary ber, inulin, & oligofructose: a review comparing their physiological
effects. Crit Rev Food Sci Nutr 33(2):103–148
Roberfroid MB (2002) Functional foods: concepts & application to inulin & oligofructose. Br J
Nutr 87(Suppl. 2):S139–S143
Roberfroid MB (2005) Introducing inulin-type fructans. Br J Nutr 93(Suppl. 1):S13–S25
Roberfroid MB, Van Loo JAE, Gibson GR (1998) The bidogenic nature of chicory inulin & its
hydrolysis products. J Nutr 128(1):11–19
Rodriguez Furlan LT, Padilla AP, Campderros ME (2014) Development of reduced fat minced
meats using inulin & bovine plasma proteins as fat replacers. Meat Sci 96:762–768
Rodriguez Furlan LT, Perez Padilla A, Campderros ME (2015) Improvement of gluten-free bread
properties by the incorporation of bovine plasma proteins & different saccharides into the
matrix. Food Chem 170:257–264
Rodríguez-García J, Salvador A, Hernando I (2014) Replacing fat & sugar with inulin in cakes:
bubble size distribution, physical & sensory properties. Food Bioprocess Technol 7:964–974
Saengthongpinit W, Sajjaanantakul T (2005) Inuence of harvest time & storage temperature on
characteristics of inulin from Jerusalem artichoke (Helianthus tuberosus L.) tubers. Postharvest
Biol Technol 37:93–100
V. Mittal et al.